Par Drugs And Chemicals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: PAR | Chemicals | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Par Drugs & Chem.

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Par Drugs And Chemicals stock performance -

mw4me loader
P/E Ratio (SA):
21.40
Market Cap:
304.5 Cr.
52-wk low:
0
52-wk high:
0

Is Par Drugs And Chemicals Ltd an attractive stock to invest in?

1. Is Par Drugs And Chemicals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Par Drugs And Chemicals Ltd is a average quality company.

2. Is Par Drugs And Chemicals Ltd undervalued or overvalued?

The key valuation ratios of Par Drugs And Chemicals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Par Drugs And Chemicals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Par Drugs And Chemicals Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Par Drugs & Chem.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Par Drugs And Chemicals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 6.9%7%6%7.8%7.2%9.2%12.1%19.9%15.8%17.3%-
Value Creation
Index
-0.5-0.5-0.6-0.4-0.5-0.3-0.10.40.10.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 27.333.333.348.842.446.355.960.875.195.897
Sales YoY Gr.-21.8%0%46.6%-13.1%9.3%20.6%8.8%23.6%27.6%-
Adj EPS 1.31.60.83.42.82.83.98.37.59.111.6
YoY Gr.-22.4%-52.4%337.2%-17.3%-0.4%37%115.8%-9.9%21.8%-
BVPS (₹) 19.320.921.524.928.232.43342.448.757.966.7
Adj Net
Profit
0.70.90.41.81.52.54.710.29.211.214
Cash Flow from Ops. 5.38.96.59.24.73.47.712.17.613.4-
Debt/CF from Ops. 7.23.74.72.753.50.80.700-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 15%17.7%19.7%27.6%
Adj EPS 23.8%26.5%33.3%21.8%
BVPS13%15.5%20.6%19%
Share Price - - 25.6% 67.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
4.65.32.510.17.610.113.62216.417.118.6
Op. Profit
Mgn %
2722.521.617.418.917.716.926.421.71922.7
Net Profit
Mgn %
2.72.71.33.83.65.48.516.812.311.714.6
Debt to
Equity
2.41.91.81.31.10.40.20.200-
Working Cap
Days
155149153108110102931011059492
Cash Conv.
Cycle
-41647513329423830323468

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 18.60%

Sales growth is growing at healthy rate in last 3 years 19.68%

Net Profit is growing at healthy rate in last 3 years 33.30%

Sales growth is not so good in last 4 quarters at 4.36%

Latest Financials - Par Drugs And Chemicals Ltd.

Standalone Consolidated
TTM EPS (₹) 11.6 -
TTM Sales (₹ Cr.) 97.3 -
BVPS (₹.) 66.7 -
Reserves (₹ Cr.) 70 -
P/BV 3.71 -
PE 21.40 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 304
Equity (₹ Cr.) 12.3
Face Value (₹) 10
Industry PE 49.3

Management X-Ray of Par Drugs & Chem.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Par Drugs & Chem.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales27333349424656617596
Operating Expenses 20262640343846455978
Manufacturing Costs08812101214141823
Material Costs0131321181924222940
Employee Cost 0122223333
Other Costs 203355567911
Operating Profit 7778889161618
Operating Profit Margin (%) 27.0%22.5%21.6%17.4%18.9%17.7%16.9%26.4%21.7%19.0%
Other Income 0000000000
Interest 4443221100
Depreciation 2233333333
Exceptional Items 0000000200
Profit Before Tax 1113336151315
Tax 0011111334
Profit After Tax 110223512911
PAT Margin (%) 2.7%2.7%1.3%3.8%3.6%5.4%8.5%19.1%12.3%11.8%
Adjusted EPS (₹)1.31.60.83.42.82.83.99.47.59.2
Dividend Payout Ratio (%)0%0%0%0%0%0%32%0%17%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 16171719212941526071
Share Capital 888884661212
Reserves 89911132534464859
Minority Interest0000000000
Debt3328262118105800
Long Term Debt252116141365400
Short Term Debt87107540300
Trade Payables57685567118
Others Liabilities 7788107910810
Total Liabilities 61595856545160767989

Fixed Assets

Gross Block54545456565757536068
Accumulated Depreciation791214172023232629
Net Fixed Assets47454342393634303438
CWIP 0000001500
Investments 0000000000
Inventories3464443355
Trade Receivables88789912121817
Cash Equivalents 1010007211622
Others Assets2212222556
Total Assets 61595856545160767989

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 597953812813
PBT 1113336151315
Adjustment 6665543133
Changes in Working Capital -22-11-3-4-1-0-5-0
Tax Paid 000-10-1-1-4-3-4
Cash Flow From Investing Activity -600-2-10-10-3-7
Capex -600-2-10-20-3-7
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 2-9-5-8-4-312-100
Net Proceeds from Shares 0000069000
Net Proceeds from Borrowing 00-5-2-1-7-10-40
Interest Paid -4-4-4-2-2-2-1-100
Dividend Paid 000000-1-1-20
Others 5-53-3-1-1-43-30
Net Cash Flow 1-11-100714-56
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)7.218.183.6914.7510.6311.3513.6825.0216.4417.29
ROCE (%)10.189.929.3612.3411.1912.4115.5628.6821.8523.2
Asset Turnover Ratio0.480.550.570.860.881.011.141.011.091.29
PAT to CFO Conversion(x)59N/A4.52.511.610.891.18
Working Capital Days
Receivable Days77848258635960666760
Inventory Days46415236302921161717
Payable Days0157184123133978610811085

Par Drugs And Chemicals Ltd Stock News

Par Drugs And Chemicals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Par Drugs & Chem. on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Par Drugs & Chem. stood at ₹304.5.
The latest P/E ratio of Par Drugs & Chem. as of 01-Jan-1970 05:30 is 21.40.
The latest P/B ratio of Par Drugs & Chem. as of 01-Jan-1970 05:30 is 3.71.
The 52-week high of Par Drugs & Chem. is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Par Drugs & Chem. is ₹97.31 ( Cr.) .

About Par Drugs And Chemicals Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.